0
0
Equatorial Guinea has made remarkable progress in its fight against tuberculosis (TB), with screening rates increasing significantly from 34% to 87% between 2020 and 2023. This progress is thanks to the implementation of a national strategy supported by World Health Organization (WHO) and the adoption of cutting-edge diagnostic tools.
Among these tools, GeneXpert – a device provided by WHO – plays a crucial role. As Dr Ana Bella Ekiri, Head of the Tuberculosis and HIV Programme at the WHO Country Office in Equatorial Guinea explains, “These new devices enable early, rapid and accurate diagnosis, particularly for multidrug-resistant tuberculosis (MDR-TB) and benefit in particular the most vulnerable populations”.
In 2023, 95% of people who fell ill with TB were diagnosed using rapid tests. GeneXpert can detect TB in just two hours, compared with several weeks using traditional methods. These tests have doubled the number of MDR-TB cases reported, revealing high rates in prisons and hospitals, where overcrowding encourages transmission. In the same year, people presenting with multidrug resistance accounted for 92% of diagnosed cases, underlining the need for urgent action to combat this public health crisis.
Despite the rise in MDR-TB cases since 2017, Equatorial Guinea is working hard to achieve the Sustainable Development Goals target of eliminating TB by 2030. WHO continues to provide technical and logistical assistance, focusing on combating MDR-TB. Specialized training, clinical guidelines update, the integration of tuberculosis diagnosis and treatment into HIV care units, and a proactive search for undiagnosed cases within communities are at the heart of this intervention.
Joana, a recovered patient, says, “I was very sick and worried when I arrived at the hospital. I believed it was HIV; but thanks to the rapid tests, I soon knew it was TB. I thought my life was over, but as time went on, I realized that it was an illness like any other that I could overcome.”
WHO has built local capacity by carrying out regular field supervision and supporting the training of 50 health professionals to improve MDR-TB case management.
“Training has enabled us to detect TB earlier and to avoid late treatment, which has considerably improved patient care,” explains Dr Manuel Eyene Bacale Ayeto, Regional Coordinator for the prevention and control of STIs, HIV/AIDS, TB and viral hepatitis in Equatorial Guinea.
WHO and local health authorities are also working to make screening and treatment services accessible in all the country’s health centres, including HIV treatment units. TB/HIV co-infection remains the leading cause of death among people living with HIV in the African region.
“The incidence of TB remains high, with 275 new cases detected each year per 100 000 population. Its constant increase is mainly due to the growth of the HIV epidemic,” explains Dr Leticia Ondo Ayecaba, Head of the TB Control Programme at the Ministry of Health.
The integrated one-stop-shop approach, which combines TB and HIV care, has also helped to improve treatment outcomes. “To halt the spread of TB, we have increased access to treatment and stepped up prevention efforts, particularly for people living with HIV, contacts of TB patients and other high-risk groups,” Dr Ayecaba adds.
Since 2022, the treatment success rate has grown, increasing from 67% in 2020 to 74% in 2023. Equatorial Guinea plans to set up a national reference laboratory for the culture of MDR-TB strains, to strengthen the country’s capacity to respond effectively to this health crisis.
“What motivates me is seeing patients go home and returning for their medication once they have recovered from the active phase of the disease. We all have a role to play in TB eradication,” says Dr Ayeto.
World Health Organization
About Author
OTHER ARTICLES
Zambia : The vital role of community health assistants in public health surveillance
Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.
Confirmed Case of Mpox in Senegal: Situation Update (as of August 27, 2025)